1. Home
  2. CPIX vs REFR Comparison

CPIX vs REFR Comparison

Compare CPIX & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • REFR
  • Stock Information
  • Founded
  • CPIX 1999
  • REFR 1965
  • Country
  • CPIX United States
  • REFR United States
  • Employees
  • CPIX N/A
  • REFR N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • REFR Multi-Sector Companies
  • Sector
  • CPIX Health Care
  • REFR Miscellaneous
  • Exchange
  • CPIX Nasdaq
  • REFR Nasdaq
  • Market Cap
  • CPIX 51.5M
  • REFR 56.9M
  • IPO Year
  • CPIX 2009
  • REFR N/A
  • Fundamental
  • Price
  • CPIX $2.17
  • REFR $1.58
  • Analyst Decision
  • CPIX
  • REFR
  • Analyst Count
  • CPIX 0
  • REFR 0
  • Target Price
  • CPIX N/A
  • REFR N/A
  • AVG Volume (30 Days)
  • CPIX 46.5K
  • REFR 128.0K
  • Earning Date
  • CPIX 11-04-2025
  • REFR 11-06-2025
  • Dividend Yield
  • CPIX N/A
  • REFR N/A
  • EPS Growth
  • CPIX N/A
  • REFR N/A
  • EPS
  • CPIX N/A
  • REFR N/A
  • Revenue
  • CPIX $41,278,349.00
  • REFR $1,227,276.00
  • Revenue This Year
  • CPIX N/A
  • REFR N/A
  • Revenue Next Year
  • CPIX N/A
  • REFR N/A
  • P/E Ratio
  • CPIX N/A
  • REFR N/A
  • Revenue Growth
  • CPIX 12.21
  • REFR N/A
  • 52 Week Low
  • CPIX $1.04
  • REFR $0.93
  • 52 Week High
  • CPIX $7.25
  • REFR $2.70
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 26.09
  • REFR 47.26
  • Support Level
  • CPIX $1.96
  • REFR $1.53
  • Resistance Level
  • CPIX $3.40
  • REFR $1.89
  • Average True Range (ATR)
  • CPIX 0.21
  • REFR 0.25
  • MACD
  • CPIX -0.13
  • REFR -0.05
  • Stochastic Oscillator
  • CPIX 10.13
  • REFR 11.11

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.

Share on Social Networks: